Popis činnosti

A variety of drugs are required for the treatment of the numerous types of cancer. Different cancers respond differently to therapeutics. Even different patients with the same cancer type respond differently to the same drug. In some cases, cancer cells develop a resistance to drugs which are initially effective in treating the disease. To address these challenges, BioApex is developing a portfolio of targeted small molecule drugs to provide the most effective therapy for each cancer type. Three of these agents are currently being evaluated in preclinical trials.